prikaz prve stranice dokumenta Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease
Pristup korisnicima matične ustanove
Znanstveni rad - Izvorni znanstveni rad
Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease
Ultrasound in Medicine & Biology, 47 (2021), 3; 428-437. https://doi.org/10.1016/j.ultrasmedbio.2020.11.015
Mikolaševic, Ivana; Domislović, Viktor; Klapan, Mia; Jurić, Toni; Lukić, Andjela; Krznarić-Zrnić, Irena; Fučkar Čupić, Dora; Štimac, Davor; Filipec Kanižaj, Tajana; Krznaric, Željko; Radić-Krišto, Delfa; Milić, Sandra; Martinović, Marko; Grubešić, Aron; Grgurević, Ivica Više autora...

Citirajte ovaj rad

Mikolaševic, I., Domislović, V., Klapan, M., Jurić, T., Lukić, A., Krznarić Zrnić, I. ... Grgurević, I. (2021). Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology, 47. (3), 428-437. doi: 10.1016/j.ultrasmedbio.2020.11.015

Mikolaševic, Ivana, et al. "Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease." Ultrasound in Medicine & Biology, vol. 47, br. 3, 2021, str. 428-437. https://doi.org/10.1016/j.ultrasmedbio.2020.11.015

Mikolaševic, Ivana, Viktor Domislović, Mia Klapan, Toni Jurić, Andjela Lukić, Irena Krznarić Zrnić, Dora Fučkar Čupić, et al. "Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease." Ultrasound in Medicine & Biology 47, br. 3 (2021): 428-437. https://doi.org/10.1016/j.ultrasmedbio.2020.11.015

Mikolaševic, I., et al. (2021) 'Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease', Ultrasound in Medicine & Biology, 47(3), str. 428-437. doi: 10.1016/j.ultrasmedbio.2020.11.015

Mikolaševic I, Domislović V, Klapan M, Jurić T, Lukić A, Krznarić Zrnić I, i sur.. Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology [Internet]. 03.2021. [pristupljeno 11.11.2024.];47(3):428-437. doi: 10.1016/j.ultrasmedbio.2020.11.015

I. Mikolaševic, et al., "Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease", Ultrasound in Medicine & Biology, vol. 47, br. 3, str. 428-437, Ožujak 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:557806. [Citirano: 11.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:557806
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease
AutorIvana Mikolaševic
AutorViktor Domislović
AutorMia Klapan
AutorToni Jurić
AutorAndjela Lukić
AutorIrena Krznarić-Zrnić
AutorDora Fučkar Čupić
AutorDavor Štimac
AutorTajana Filipec Kanižaj
AutorŽeljko Krznaric
AutorDelfa Radić-Krišto
AutorSandra Milić
AutorMarko Martinović
AutorAron Grubešić
AutorIvica Grgurević
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
We evaluated the diagnostic accuracy of the controlled attenuation parameter (CAP) and liver stiffness measurements (LSM) measured with either an M or XL probe against liver biopsy (LB) in patients with non-alcoholic fatty liver disease (NAFLD). This study was a cross-sectional prospective study that included 179 NAFLD patients. With a cutoff value for CAP >= 345, we can exclude significant steatosis in 87% (79.4%-92.5%) of our population. With respect to the LSM, the highest accuracy was obtained for F >= F3 (area under the receiver operating characteristic curve [AUROC] = 0.98) and F = F4 (AUROC = 0.98). In a multivariable linear regression model, significant predictors influencing LSM were fibrosis stage (beta = 2.6, p < 0.001) as a positive predictor and lobular inflammation (beta = -0.68, p = 0.04) as a negative predictor, without significant influence after adjustment for CAP and probe type. We found that CAP is a satisfactory method for excluding advanced steatosis, while LSM is a good non-invasive marker for the exclusion of fibrosis.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaUltrasound in Medicine & Biology
Brojčani podacivol. 47, br. 3, str. 428-437
p-ISSN0301-5629
DOIhttps://doi.org/10.1016/j.ultrasmedbio.2020.11.015
URN:NBNurn:nbn:hr:184:557806
Datum objave publikacije2021-03
URL dokumentahttps://linkinghub.elsevier.com/retrieve/pii/S0301562920305226
Vrsta resursaTekst
Prava pristupaInstitucijski pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-09-20 12:03:57